Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone

Kae Fukuyama, Toshihiro Ichiki, Kotaro Takeda, Tomotake Tokunou, Naoko Iino, Satoko Masuda, Minako Ishibashi, Kensuke Egashira, Hiroaki Shimokawa, Katsuya Hirano, Hideo Kanaide, Akira Takeshita

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Thyroid hormone has a broad effect on cardiovascular system. 3,3′,5-triiodo-L-thyronine (T3), a biologically active form of thyroid hormone, increases cardiac contractility. T3 causes arterial relaxation and reduction of systemic vascular resistance, resulting in an increase in cardiac output. However, the molecular mechanisms of vascular relaxation by T3 are incompletely characterized. We studied the effect of T3 on the angiotensin (Ang) II type 1 receptor (AT1R) expression in vascular smooth muscle cells. T3 dose-dependently decreased expression levels of AT1R mRNA, with a peak at 6 hours of stimulation. Binding assay using [125I] Sar1-Ile8-Ang II revealed that AT1R number was decreased by stimulation with T3 without changing the affinity to Ang II. T3 reduced calcium response of vascular smooth muscle cells to Ang II by 26%. AT1R promoter activity measured by luciferase assay was reduced by 50% after 9 hours of T3 administration. mRNA stability was also decreased by T3. Real-time quantitative reverse transcription-polymerase chain reaction and Western blot analysis revealed that AT1R mRNA and protein were downregulated in the aorta of T3-treated rats. These results suggest that T3 downregulates AT1R expression both at transcriptional and posttranscriptional levels, and attenuates biological function of Ang II. Our results suggest that downregulation of AT1R gene expression may play an important role for T3-induced vascular relaxation.

Original languageEnglish
Pages (from-to)598-603
Number of pages6
JournalHypertension
Volume41
Issue number3 I
DOIs
Publication statusPublished - Mar 1 2003

Fingerprint

Angiotensin Type 1 Receptor
Thyroid Hormones
Angiotensin II
Blood Vessels
Down-Regulation
Vascular Smooth Muscle
Smooth Muscle Myocytes
Thyronines
Messenger RNA
RNA Stability
Cardiovascular System
Luciferases
Cardiac Output
Vascular Resistance
Reverse Transcription
Aorta
Western Blotting
Calcium
Gene Expression
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Fukuyama, K., Ichiki, T., Takeda, K., Tokunou, T., Iino, N., Masuda, S., ... Takeshita, A. (2003). Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension, 41(3 I), 598-603. https://doi.org/10.1161/01.HYP.0000056524.35294.80

Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. / Fukuyama, Kae; Ichiki, Toshihiro; Takeda, Kotaro; Tokunou, Tomotake; Iino, Naoko; Masuda, Satoko; Ishibashi, Minako; Egashira, Kensuke; Shimokawa, Hiroaki; Hirano, Katsuya; Kanaide, Hideo; Takeshita, Akira.

In: Hypertension, Vol. 41, No. 3 I, 01.03.2003, p. 598-603.

Research output: Contribution to journalArticle

Fukuyama, K, Ichiki, T, Takeda, K, Tokunou, T, Iino, N, Masuda, S, Ishibashi, M, Egashira, K, Shimokawa, H, Hirano, K, Kanaide, H & Takeshita, A 2003, 'Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone', Hypertension, vol. 41, no. 3 I, pp. 598-603. https://doi.org/10.1161/01.HYP.0000056524.35294.80
Fukuyama, Kae ; Ichiki, Toshihiro ; Takeda, Kotaro ; Tokunou, Tomotake ; Iino, Naoko ; Masuda, Satoko ; Ishibashi, Minako ; Egashira, Kensuke ; Shimokawa, Hiroaki ; Hirano, Katsuya ; Kanaide, Hideo ; Takeshita, Akira. / Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. In: Hypertension. 2003 ; Vol. 41, No. 3 I. pp. 598-603.
@article{644f0c652ae6453ebc06b02665964c7d,
title = "Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone",
abstract = "Thyroid hormone has a broad effect on cardiovascular system. 3,3′,5-triiodo-L-thyronine (T3), a biologically active form of thyroid hormone, increases cardiac contractility. T3 causes arterial relaxation and reduction of systemic vascular resistance, resulting in an increase in cardiac output. However, the molecular mechanisms of vascular relaxation by T3 are incompletely characterized. We studied the effect of T3 on the angiotensin (Ang) II type 1 receptor (AT1R) expression in vascular smooth muscle cells. T3 dose-dependently decreased expression levels of AT1R mRNA, with a peak at 6 hours of stimulation. Binding assay using [125I] Sar1-Ile8-Ang II revealed that AT1R number was decreased by stimulation with T3 without changing the affinity to Ang II. T3 reduced calcium response of vascular smooth muscle cells to Ang II by 26{\%}. AT1R promoter activity measured by luciferase assay was reduced by 50{\%} after 9 hours of T3 administration. mRNA stability was also decreased by T3. Real-time quantitative reverse transcription-polymerase chain reaction and Western blot analysis revealed that AT1R mRNA and protein were downregulated in the aorta of T3-treated rats. These results suggest that T3 downregulates AT1R expression both at transcriptional and posttranscriptional levels, and attenuates biological function of Ang II. Our results suggest that downregulation of AT1R gene expression may play an important role for T3-induced vascular relaxation.",
author = "Kae Fukuyama and Toshihiro Ichiki and Kotaro Takeda and Tomotake Tokunou and Naoko Iino and Satoko Masuda and Minako Ishibashi and Kensuke Egashira and Hiroaki Shimokawa and Katsuya Hirano and Hideo Kanaide and Akira Takeshita",
year = "2003",
month = "3",
day = "1",
doi = "10.1161/01.HYP.0000056524.35294.80",
language = "English",
volume = "41",
pages = "598--603",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "3 I",

}

TY - JOUR

T1 - Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone

AU - Fukuyama, Kae

AU - Ichiki, Toshihiro

AU - Takeda, Kotaro

AU - Tokunou, Tomotake

AU - Iino, Naoko

AU - Masuda, Satoko

AU - Ishibashi, Minako

AU - Egashira, Kensuke

AU - Shimokawa, Hiroaki

AU - Hirano, Katsuya

AU - Kanaide, Hideo

AU - Takeshita, Akira

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Thyroid hormone has a broad effect on cardiovascular system. 3,3′,5-triiodo-L-thyronine (T3), a biologically active form of thyroid hormone, increases cardiac contractility. T3 causes arterial relaxation and reduction of systemic vascular resistance, resulting in an increase in cardiac output. However, the molecular mechanisms of vascular relaxation by T3 are incompletely characterized. We studied the effect of T3 on the angiotensin (Ang) II type 1 receptor (AT1R) expression in vascular smooth muscle cells. T3 dose-dependently decreased expression levels of AT1R mRNA, with a peak at 6 hours of stimulation. Binding assay using [125I] Sar1-Ile8-Ang II revealed that AT1R number was decreased by stimulation with T3 without changing the affinity to Ang II. T3 reduced calcium response of vascular smooth muscle cells to Ang II by 26%. AT1R promoter activity measured by luciferase assay was reduced by 50% after 9 hours of T3 administration. mRNA stability was also decreased by T3. Real-time quantitative reverse transcription-polymerase chain reaction and Western blot analysis revealed that AT1R mRNA and protein were downregulated in the aorta of T3-treated rats. These results suggest that T3 downregulates AT1R expression both at transcriptional and posttranscriptional levels, and attenuates biological function of Ang II. Our results suggest that downregulation of AT1R gene expression may play an important role for T3-induced vascular relaxation.

AB - Thyroid hormone has a broad effect on cardiovascular system. 3,3′,5-triiodo-L-thyronine (T3), a biologically active form of thyroid hormone, increases cardiac contractility. T3 causes arterial relaxation and reduction of systemic vascular resistance, resulting in an increase in cardiac output. However, the molecular mechanisms of vascular relaxation by T3 are incompletely characterized. We studied the effect of T3 on the angiotensin (Ang) II type 1 receptor (AT1R) expression in vascular smooth muscle cells. T3 dose-dependently decreased expression levels of AT1R mRNA, with a peak at 6 hours of stimulation. Binding assay using [125I] Sar1-Ile8-Ang II revealed that AT1R number was decreased by stimulation with T3 without changing the affinity to Ang II. T3 reduced calcium response of vascular smooth muscle cells to Ang II by 26%. AT1R promoter activity measured by luciferase assay was reduced by 50% after 9 hours of T3 administration. mRNA stability was also decreased by T3. Real-time quantitative reverse transcription-polymerase chain reaction and Western blot analysis revealed that AT1R mRNA and protein were downregulated in the aorta of T3-treated rats. These results suggest that T3 downregulates AT1R expression both at transcriptional and posttranscriptional levels, and attenuates biological function of Ang II. Our results suggest that downregulation of AT1R gene expression may play an important role for T3-induced vascular relaxation.

UR - http://www.scopus.com/inward/record.url?scp=0037338269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037338269&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000056524.35294.80

DO - 10.1161/01.HYP.0000056524.35294.80

M3 - Article

C2 - 12623965

AN - SCOPUS:0037338269

VL - 41

SP - 598

EP - 603

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 3 I

ER -